Skip to main content
. 2019 Jan 7;2019(1):CD009841. doi: 10.1002/14651858.CD009841.pub3

2.14. Analysis.

2.14

Comparison 2 Ivacaftor (VX‐770) versus placebo in people with at least one G551D CFTR mutation, Outcome 14 FEV1 (% predicted) ‐ mean absolute change from baseline.